Two Former Covance Senior Executives Join MedAvante Board of Directors

Hamilton, NJ (June 21, 2016) – MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced two new members of its Board of Directors: Richard F. Cimino, former Covance, Inc. EVP and Group President of Clinical Development and Commercialization Services, and Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance.

MedAvante Research Shows Improved Psychiatric Assessments in Clinical Trials 

Virgil eCOA Reduces HAM-D Item Scoring Errors Up To 70%

Scottsdale AZ (June 1, 2016) – MedAvante, Inc., the leading global scientific clinical data services company, today presented research at the 2016 American Society of Clinical Psychopharmacology (ASCP) meeting quantifying error reduction in actual clinical trials of treatments for major depressive disorder (MDD). The new study compares traditional paper-based assessments in clinical trials with the Virgil® Investigative Study Platform, which uses a digital tablet to administer and score clinical outcome assessments (eCOA) and capture source data (eSource).

MedAvante Presents eSource Research at ACNP

Strategies are needed to improve quality of rater administration of many psychiatric instruments. The SCI-PANSS and the SIGMA (MADRS) are two of the most commonly used measures of psychopathology. To...

Read More

Weir Joins MedAvante in New Global Operations Post

  Software Development Pro Joins Growing Force in Clinical Trial Technology   Hamilton, NJ (October 27, 2015) – MedAvante, Inc., a leading global provider of science-driven, technology-enabled signal detection solutions for studies...

Read More